ASURAGEN INC — Form D
ASURAGEN INC of AUSTIN, TX, a company, filed a Form D exempt-offering notice with the SEC on 2011-08-11. The offering totals $10.0M, of which $5.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2011-08-11
- Form: D
- Accession: 0001358480-11-000004
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $10.0M
- Amount sold: $5.0M
- Remaining: $5.0M
- Investors: 1
- Date of first sale: 2011-07-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-164309
Issuer
- Name: ASURAGEN INC
- CIK: 0001358480
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 2150 Woodward Street, AUSTIN, TX, 78744
- Phone: (512) 681-5200
Officers, directors & promoters (14)
| Name | Role | Location |
|---|
| Lynne J Hohlfeld | Executive Officer | Austin, TX |
| Ana J Ward | Executive Officer | Austin, TX |
| Carol J Berry | Executive Officer | Austin, TX |
| Matthew M Winkler | Director | Austin, TX |
| Matthew M Winkler | Executive Officer | Austin, TX |
| David J Sargent | Director | Austin, TX |
| David J Rubin | Director | Austin, TX |
| Evan S Melrose | Director | Austin, TX |
| John E Mooney | Director | Austin, TX |
| Rolland M Carlson | Director | Austin, TX |
| Rolland M Carlson | Executive Officer | Austin, TX |
| Robert J Dominici | Director | Austin, TX |
| Lyle E Arnold | Director | Austin, TX |
| Christopher D Earl | Director | Austin, TX |
Other filings by this issuer (1)
More